RAPP – rapport therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Rapport Therapeutics (RAPP) was downgraded by Wall Street Zen from "h
Rapport Therapeutics (RAPP) had its price target raised by Wells Fargo & Company from $43.00 to $46.00. They now have an "overweight" rating on the stock.
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
Rapport Therapeutics GAAP EPS of -$0.72 misses by $0.03 [Seeking Alpha]
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Form S-3ASR Rapport Therapeutics,
Form S-8 Rapport Therapeutics,
Form 10-K Rapport Therapeutics, For: Dec 31
Form 8-K Rapport Therapeutics, For: Mar 10
Form 4 Rapport Therapeutics, For: Mar 05 Filed by: Gault Cheryl
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.